FDA approves Perioperative Imfinzi Regimen for muscle-invasive bladder cancer The FDA has approved AstraZeneca’s Imfinzi in combination with enfortumab vedotin as neoadjuvant treatment, followed by Imfinzi monotherapy after surgery, for adults with muscle-invasive bladder cancer who. ..
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan